Categories: News

Crescent Innovations reports strong interest in asset sale

WESTFORD, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) — Crescent Innovations Inc. reports that activity surrounding sale of its joint, bone and skin repair technology remains strong even at this late date. Crescent Innovations had previously announced the sealed bid deadline for sale of its assets had been moved to September 13, 2024 due to high interest.

Al Prescott noted that, “Not only has the activity in tissue regeneration been brisk, but the veterinary, agricultural and waste water treatment interest has increased.”

Poly-gamma-glutamic acid, and the other associated technologies, are novel biological polymers with unique and relevant properties to large and diverse market areas. They include;

  • Medical device – osteoarthritis, joint repair and bone repair
  • Wound care – diabetic ulcer, burns and skin repair
  • Beauty – injectable beauty compounds similar to botox
  • Seeding and fertilizing
  • And Waste water recovery
  • Drinking water purification

Chris Finn, is president of the advisory firm Alternotio which Crescent Innovations has retained Alternotio to sell these assets using a sealed bid sales process. The assets will be sold at a sealed bid sale on September 13, 2024, at noon. Parties interested in purchasing any or all of the assets must sign a confidentiality agreement, which can be obtained by contacting Chris Finn at info@alternotio.com or calling +1 (978) 882-2586. Negotiated offers are welcome, but any negotiated sale must be concluded prior to opening bids on the date specified above and must conform to the terms set forth for sealed bids.

About Crescent Innovations Inc.

Crescent Innovations Inc. is a firm focused on the development of biological polymers to create non surgical regenerative solutions for chronic conditions. The firm currently is focused on innovating technology to solve TMJ disorders and singular maladies. If interested in TMJ disorders, please contact Crescent Innovations directly at www.crescentinnovations.com

About Alternotio.

Alternotio is an advisory firm, that specializes in the sale of non-lead and distressed intellectual property. Alternotio occasionally works with unique tangible assets that have a substantial intellectual property component.

Contacts:

Al Prescott, alprescott@crescentinnovations

Chris Finn, info@alternotio.com 

Staff

Recent Posts

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

6 hours ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

9 hours ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

11 hours ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

12 hours ago

Thought Technology Ltd Celebrates 50 Years of Innovation and Excellence

Montreal-based Thought Technology Ltd wraps up its 50th year in business providing psychophysiological instrumentation to…

12 hours ago

Study Finds Telemedicine Improves Care for Children with Eye Cancer

The new research from eye care nonprofit Orbis International, supported by Heidelberg Engineering, shows how…

12 hours ago